Enalapril
Enalapril
Enalapril
Thermo Scientific Chemicals

Enalapril

Long-acting ACE inhibitor and antihypertensive | CAS: 75847-73-3 | C20H28N2O5 | 376.453 g/mol
製品番号(カタログ番号) J60750.03
または、製品番号J60750-03
価格(JPY)
-
数量:
1 g
一括またはカスタム形式をリクエストする
化学物質識別子
CAS75847-73-3
IUPAC Name(2S)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]pyrrolidine-2-carboxylic acid
Molecular FormulaC20H28N2O5
InChI KeyGBXSMTUPTTWBMN-XIRDDKMYSA-N
SMILESCCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O
さらに表示
Appearance (Color)White
FormCrystals or powder or crystalline powder
Assay from Supplier's CofA≥98.0%
Enalapril is used in the treatment of hypertension, diabetic nephropathy, and some types of chronic heart failure. It has been proven to protect the function of the kidneys in hypertension, heart failure, and diabetes, and may be used in the absence of hypertension for its kidney protective effects. It is widely used in chronic kidney failure.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Applications
Enalapril is used in the treatment of hypertension, diabetic nephropathy, and some types of chronic heart failure. It has been proven to protect the function of the kidneys in hypertension, heart failure, and diabetes, and may be used in the absence of hypertension for its kidney protective effects. It is widely used in chronic kidney failure.

Solubility
Soluble in water at 25mg/ml

Notes
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Store away from strong oxidizing agents, heat.
RUO – Research Use Only

General References:

  1. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure : Results of the Cooperative North Scandinavian Enalapril Survival Study. N Engl J Med . 1987, 316 1429-1435.
  2. S. Yusuf, FRCP,;, C.J. Pepine, MD,; C. Garces, MSc,; H. Pouleur, MD,; M. Rousseau, MD,; D. Salem, MD,; J. Kostis, MD,; C. Benedict, MD,; M. Bourassa, MD. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions . Journal name. 1992, 340, ( 8829), 1173-1178.